Blar i forfatter "Antonsen, Margaret Aarag"

Viser treff 1-2 av 2

    • Medication Errors and Safety Culture in a Norwegian Hospital 

      Waaseth, Marit; Ademi, Adelina; Fredheim, Mette; Antonsen, Margaret Aarag; Brox, Nina M Bjæring; Lehnbom, Elin (Journal article; Tidsskriftartikkel; Peer reviewed, 2019)
      Medication errors are associated with adverse health outcomes and may prolong hospital stays and increase societal costs. Safety initiatives to reduce adverse health outcomes should be based on reliable information of current shortcomings. The aim of this study was to identify barriers to medication error reporting in a hospital and to describe heath personnel’s views of the safety culture. Seven ...

    • Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis 

      Norum, Jan; Antonsen, Margaret Aarag; Tollåli, Geir; Al-Shibli, Khalid; Andersen, Gry; Svanqvist, Kristin-Helene; Helbekkmo, Nina (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-07-29)
      1 Norum J, et al . ESMO Open 2017; 2 :e000222. doi:10.1136/esmoopen-2017-000222 Open Access Abstr A ct Background P embrolizumab is a new drug approved in several countries for second-line therapy in non-small cell lung cancer (NSCLC) being programmed cell death ligand (PD-L1) positive. This drug has a high cost, and the cost- effectiveness ratio has been debated. Patients ...